期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

细胞色素P4501B1基因多态性与乳腺癌易感性 被引量：1

暂未订购
导出
摘要 血清雌激素的浓度是患乳腺癌危险的主要决定因素之一 ,雌激素在乳腺局部可通过细胞色素氧化酶P4501B1的作用代谢为4_羟基雌激素而致癌。本文通过分析雌激素—细胞色素氧化酶P4501B1—乳腺癌之间的相互联系 。
作者 黄平 丁惠萍 任华益
机构地区 湖南省肿瘤医院
出处 《中国肿瘤》 CAS 2002年第3期161-163,共3页 China Cancer
基金 湖南省卫生厅立项课题 (2001-Y -77)
关键词 细胞色素氧化酶P450 基因多态性 乳腺肿瘤 易感性
分类号 R737.902 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1BaileyLR,RoodiN,DupontWD,etal.AssociationofcytochromeP4501B1(CYP1B1) polymorphismwithsteroidreceptorstatusinbreastcancer[].Cancer Research.1998
  • 2HellmoldH,RylanderT,MagnyssonM,etal.Characteriza_tionofcytochromeP450enzymesinhumanbreastcancertissuefromreductionmammaplasties[].JClinEndocrinolMetab.1998
  • 3ShimadaT,WatanabeJ,KawajiriK,etal.CatalyticpropertiesofpolymorphichumancytochromeP4501B1variants[].Carcinogenesis.1999
  • 4StoilovI,AkarsuAN,AlozieI,etal.Sequenceanalysisandhomologymodelingsuggestthatprimarycongenitalglaucomaon2pl21resultsfrommutationsdisruptingeitherthehingeregionortheconservedcorestructuresofcytochromeP4501B1[].AmJHumGenet.1998
  • 5WatanabeJ,ShimadaT,GillamEM,etal.AssociationofCYP1B1geneticpolymorphismwithincidencetobreastandlungcancer[].Pharmacogenetics.2000
  • 6BernsteinL,RossRK.Endogenoushormonesandbreastcancer[].Epidemiologic Reviews.1993
  • 7ZhengW,XieDW,JinF,etal.B1andriskofbreastcancer[].CancerEpidemiolBiomarkersPrev.2000
  • 8ShimadaT,HayesCL,YamazakiH,etal.Activationofchemically diverse procarcinogensby humancytochremeP4501B1[].Cancer Research.1996
  • 9MurrayGI,TaylorMC,McfadyenNC,etal.Tumourspecificex pressionofcytochromeP450CYP1B1[].Cancer Research.1997
  • 10HannaIH,DawlingS,RoodiN,etal.CytochromeP4501B1(CYP1B1)pharmacogenetics:Associationofpolymorphismwithfunctionaldifferencesinestrogenhydroxylationactivity[].Cancer Research.2000

同被引文献13

  • 1Lewis D F V, Moereels H, Lake B G, Ioannides C, Parke D V. Molecular modeling of enzymes and receptors involved in carcinogenesis: QSARs and compact-3D[J]. Drug Metab Rev, 1994, 26: 261-285.
  • 2Stack D E, Byun J, Gross M L, et al. Molecular characteristics of catechol estrogen quinines in reaction with deoxyribonucleosides[J]. Chem Res Toxicol, 1996, 9:851-859.
  • 3Pang S, Cao J Q, Katz B H, et al. Inductive and inhibitory effects of non-orthosubstituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1[J]. Biochem Pharmacol, 1999, 58:29-38.
  • 4Stupans I, Ryan A J. In vitro inhibition of 3-methylcholanthrene-induced rat hepatic aryl hydrocarbon hydroxylase by 8-acyl-7-hydroxycoumarins. Structure-activity relationships and metabolite profiles[J]. Biochem Pharmacol, 1984, 33:131-139.
  • 5Kleiner H E, VulimiriS V, Reed M J, et al. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation[J]. Chem Res Toxicol, 2002, 15:226-235.
  • 6Shimada T, Iwasaki M, Martin M V, et al. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002[J]. Cancer Res, 1989, 49:3218-3228.
  • 7Zhai S, Dai R, Wei X, et al. Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes[J]. Life Sci, 1998, 63:PL119-PL123.
  • 8Doostdar H, Burke M D, Mayer R T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1[J]. Toxicology, 2000, 144:31-38.
  • 9Chun Y J, Ryu S Y, Jeong T C, et al. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin[J]. Drug Metab Dispos, 2001, 29:389-393.
  • 10Chun Y J, Kim S, Kim D, et al. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis[J]. Cancer Res, 2001, 61:8164-8170.

引证文献1

二级引证文献3

中国肿瘤
2002年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部